Early Ultrasound and Maternal Biochemical Markers to Evaluate the Risk of Down Syndrome During the First Trimester

University Hospital, Strasbourg, France

Status: Completed

Conditions: Down Syndrome

Treatments: Device: echography; Other: blood sample

Study type: Observational

Funder types: Other

Identifiers

NCT00287417

3032

Details and patient eligibility

About

The aim of the study is to evaluate the risk of Down syndrome during the first trimester of the pregnancy. The risk assessment is evaluated using early ultrasound and maternal biochemical markers.

Enrollment: 20,000 patients

Sex: Female

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Female > 18 years old
• Pregnant

Exclusion criteria

• Maternal age < 18 years old, twin pregnancy